Evidence map›Paper›PMID 28281682›Full record

Trial reportScientific reports2017

Screening for diabetes mellitus among tuberculosis patients in Southern Nigeria: a multi-centre implementation study under programme settings.

Ngozi Ekeke, Kingsley N Ukwaja, Joseph N Chukwu, Charles C Nwafor, Anthony O Meka, Eruke E Egbagbe, Festus O Soyinka, Isaac Alobu, Ifeanyi Agujiobi, Samuel Akingbesote and 7 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Adverse pregnancy outcomes and complications of tuberculosis in pregnant women.Frontiers in cellular and infection microbiology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Ngozi EkekeMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Kingsley N UkwajaDepartment of Medicine, Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.
Joseph N ChukwuMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Charles C NwaforMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Anthony O MekaMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Eruke E EgbagbeDepartment of Medicine, University of Benin Teaching Hospital, Benin City, Edo State, Nigeria.
Festus O SoyinkaOgun State Tuberculosis and Leprosy Control Programme, Ministry of Health, Abeokuta, Ogun State, Nigeria.
Isaac AlobuEbonyi State Tuberculosis and Leprosy Control Programme, Ministry of Health, Abakaliki, Ebonyi State, Nigeria.
Ifeanyi AgujiobiEnugu State Tuberculosis and Leprosy Control Programme, Ministry of Health, Enugu, Enugu State, Nigeria.
Samuel AkingbesoteOndo State Tuberculosis and Leprosy Control Programme, Ministry of Health, Akure, Ondo State, Nigeria.
Osagie IgbinigieEdo State Tuberculosis and Leprosy Control Programme, Ministry of Health, Benin City, Edo State, Nigeria.
Job B OfforCross River State Tuberculosis and Leprosy Control Programme, Ministry of Health, Calabar, Cross River State, Nigeria.
Nelson O MadichieMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Chukwuka AlphonsusMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Moses C AnyimMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Obinna K MbahMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
Daniel C OshiMedical Department, German Leprosy and TB Relief Association, Enugu, Enugu State, Nigeria.
University of Benin Teaching Hospital · NGCross River University of Technology · NGEbonyi State University · NGEnugu State University of Science and Technology · NGFederal Medical Centre · NGFederal Teaching Hospital Abakaliki · NGOndo State University of Science and Technology · NGUniversity of the West Indies System · JM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Implementation studies are recommended to assess the feasibility and effectiveness of programmes. In Nigeria, little is known about the burden of diabetes mellitus (DM) among tuberculosis (TB) patients. The objective of this study was to determine screening efficacy, prevalence of DM and determinants of DM among TB patients. We report on a multi-centre implementation study carried-out in 13 health facilities in six States of Southern Nigeria. All newly diagnosed TB patients registered from March to October 2015 were screened for DM using current World Health Organisation guidelines. Overall, 2094 TB patients were evaluated, 196 (9.4%) were found to have DM. The prevalence of newly diagnosed DM was 5.5% (115/2094). DM prevalence varied according to age group; occurring in 2.2% of patients aged ≤ 25 years and 16.9% in patients aged (56-65) years. The additional yield of DM was 59% while the number needed to screen to detect a new case of DM was 18. Factors associated with DM were; age >40 years (aOR2.8, CI 2.1-3.9), rural residence (aOR2.3, 1.6-3.2), private health facility care (aOR2.0, 1.4-2.7), and having an occupation that engages in vigorous activity (aOR0.6, 0.4-0.9). The burden of DM among TB patients is high. Prioritization of DM screening for TB patients is indicated.

Indexed as

AdultAge FactorsDiabetes ComplicationsFemaleHumansMaleMiddle AgedNigeriaPrevalenceTuberculosis

Identifiers

PMID28281682
PMCPMC5345020
OpenAlexW2594591513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.